Compugen (CGEN) Consolidated Net Income (2009 - 2026)
Compugen recorded quarterly Consolidated Net Income of $7.7 million in Q1 2026, up 7.59% quarter-over-quarter from $7.1 million in Q1 2025, and up 7.59% year-over-year from $7.1 million in Q1 2025.
Compugen's Consolidated Net Income history runs 2 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 7.59% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $14.8 million (up 107.59% YoY), while the FY2013 annual figure was -$14.1 million, down 3.34% from the prior year.
- Consolidated Net Income came in at $7.7 million for Q1 2026 at Compugen, up from $7.1 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $7.7 million in Q1 2026 to a low of $7.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 7.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.66 Mn |
| Dec 31, 2025 | 56.74 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -21.61 Mn |
| Mar 31, 2025 | 7.12 Mn |
| Dec 31, 2024 | -6.12 Mn |
| Sep 30, 2024 | 10.28 Mn |
| Jun 30, 2024 | -16.62 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 9.71 Mn |
| Sep 30, 2023 | -9.85 Mn |
| Jun 30, 2023 | -28.00 Mn |
| Mar 31, 2023 | 9.31 Mn |
| Dec 31, 2022 | -3.09 Mn |
| Sep 30, 2022 | -11.75 Mn |
| Jun 30, 2022 | 28.56 Mn |
| Mar 31, 2022 | -9.71 Mn |
| Dec 31, 2021 | -8.65 Mn |
| Sep 30, 2021 | -8.18 Mn |
| Jun 30, 2021 | -9.50 Mn |
| Mar 31, 2021 | -9.91 Mn |
| Dec 31, 2020 | -8.56 Mn |
| Sep 30, 2020 | -7.76 Mn |
| Jun 30, 2020 | -6.25 Mn |
| Mar 31, 2020 | -7.13 Mn |
| Dec 31, 2019 | -6.46 Mn |
| Sep 30, 2019 | -6.49 Mn |
| Jun 30, 2019 | -6.70 Mn |
| Mar 31, 2019 | -8.41 Mn |
| Dec 31, 2018 | -9.40 Mn |
| Sep 30, 2018 | -3.11 Mn |
| Jun 30, 2018 | -10.19 Mn |
| Mar 31, 2018 | 104,000.00 |
| Dec 31, 2017 | -9.31 Mn |
| Sep 30, 2017 | -9.87 Mn |
| Jun 30, 2017 | -9.26 Mn |
| Mar 31, 2017 | -8.78 Mn |
| Dec 31, 2016 | -8.49 Mn |
| Sep 30, 2016 | -7.78 Mn |
| Jun 30, 2016 | -6.61 Mn |
| Mar 31, 2016 | -8.87 Mn |
| Dec 31, 2015 | -472,000.00 |
| Sep 30, 2015 | -6.74 Mn |
| Jun 30, 2015 | -6.81 Mn |
| Mar 31, 2015 | -6.14 Mn |
| Dec 31, 2014 | -1.48 Mn |
| Sep 30, 2014 | -5.40 Mn |
| Jun 30, 2014 | -2.20 Mn |
| Mar 31, 2014 | -1.90 Mn |
| Dec 31, 2013 | -2.93 Mn |
| Sep 30, 2013 | -4.74 Mn |
| Jun 30, 2013 | -3.04 Mn |
| Mar 31, 2013 | -3.37 Mn |
| Dec 31, 2012 | -5.37 Mn |
| Sep 30, 2012 | -3.51 Mn |
| Jun 30, 2012 | -5.29 Mn |
| Mar 31, 2012 | -3.12 Mn |
| Dec 31, 2011 | -3.07 Mn |
| Sep 30, 2011 | -3.11 Mn |
| Jun 30, 2011 | -4.59 Mn |
| Mar 31, 2011 | -2.43 Mn |
| Dec 31, 2010 | -2.30 Mn |
| Sep 30, 2010 | -1.92 Mn |
| Jun 30, 2010 | -978,000.00 |
| Mar 31, 2010 | -2.72 Mn |
| Dec 31, 2009 | -2,000.00 |
| Sep 30, 2009 | 27,000.00 |
| Jun 30, 2009 | 5,000.00 |
| Mar 31, 2009 | -5,000.00 |